With First Trials On Horizon, Value Of Growing Philly Xarelto Claims Uncertain

It might be more than a year from now, but litigation centered on the blood thinner Xarelto could eventually come to trial in Philadelphia courtrooms – and one attorney says the thousands of cases filed over the similar drug Pradaxa may serve as a guide to the value of those claims.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Source Type: news